Boston Therapeutics, Inc (BTHE) Today, BTHE has shed (-21.43%) down -0.30 at $1.10 with 8,540 shares in play thus far (ref. google finance Delayed: 2:09PM EDT October 8, 2013). Boston Therapeutics has previously closed the final tranche of approximately $1.8 million to bring total gross proceeds of approximately $5.3 million from the private placement of Common […]
↧